Medik8 CRYSTAL RETINAL 6 Stable Retinal Night Serum delivers the power of 6 with 0.06% retinaldehyde. It is suitable for evening care for regular vitamin A users, including those transitioning from Crystal Retinal 3.

Key Benefits

The results of an independent clinical study of Crystal Retinal 6 are based on monitoring 33 participants over 12 weeks.

• Wrinkle visibility reduced by 20%.
• Visible hyperpigmentation reduced by 20%.
• Skin firmness increased by 11%.
• Six retinaldehyde concentrations in the Crystal Retinal range allow progression from 0.01% to 0.24%.

Clinical data at this concentration capture changes in wrinkle visibility, hyperpigmentation and skin firmness.

Ingredients

• Double-encapsulated retinaldehyde at a concentration of 0.06% represents a form of vitamin A.
• Hyaluronic acid, according to the manufacturer, draws moisture into the skin and supports its supple appearance.
• Glycerin helps retain moisture in the skin.
• The formula contains antioxidant vitamin E.
• The product is certified by The Vegan Society.

Retinaldehyde is complemented here by ingredients focused on maintaining moisture and a supple-looking complexion.

Use and Dosage

Perform a patch test at least 24 hours before first use. Introduce the serum gradually:

• twice a week for the first two weeks,
• every other day for the following two weeks,
• then every evening.

After your evening cleanse, apply two pumps to the face and neck and allow the serum to absorb. Then apply a moisturiser. Always apply an SPF product in the morning. Do not apply the serum directly around the eye area.

Gradually increasing the frequency will allow you to incorporate the power of 6 into your regular evening routine following the recommended regimen.

Packaging and Volume

• Volume: 30 ml.
• One tube lasts approximately 100 uses.

About the Brand

Medik8 was founded in 2009 by British scientist Elliot Isaacs. Crystal Retinal was developed in the Medik8 laboratories near London in 2018, and the brand holds a patent for stabilising retinaldehyde in a serum with multiple concentration levels. In 2023, it received B Corp certification.

The development of the range is built on patented retinaldehyde stabilisation and a system of progressive concentrations.